Proxim Diagnostics Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $18M

  • Investors
  • 4

Proxim Diagnostics General Information

Description

Developer of an immunodiagnostic device intended to market a new generation of diagnostic tests on a handheld platform. The company's device performs important laboratory tests using whole blood without any sacrifice in sensitivity and precision and uses a disposable test cartridge, which can be manufactured at an affordable cost, enabling hospitals to perform tests within minutes and treat patients as early as possible.

Contact Information

Website
www.proximdx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Services
Primary Office
  • 2065 Martin Avenue
  • Suite 101
  • Santa Clara, CA 95050
  • United States
+1 (888) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Proxim Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series D) 21-Mar-2023 $18M 000.00 0000 Completed Generating Revenue
3. Later Stage VC (Series C) 02-Oct-2018 00.000 00.00 000.00 Completed Generating Revenue
2. Later Stage VC (Series B) 10-Mar-2016 $2.27M $3.19M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 10-Nov-2010 $923K $923K 00.000 Completed Product In Beta Test
To view Proxim Diagnostics’s complete valuation and funding history, request access »

Proxim Diagnostics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series C 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series B 7,416,235 $0.000010 $0.04 $0.46 $0.46 1x $0.46 17.88%
Series A 10,483,447 $0.000010 $0.01 $0.09 $0.09 1x $0.09 25.28%
To view Proxim Diagnostics’s complete cap table history, request access »

Proxim Diagnostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an immunodiagnostic device intended to market a new generation of diagnostic tests on a handheld platform.
Diagnostic Equipment
Santa Clara, CA
6 As of 2023
000.00
000 0000-00-00
00000000000 000.00

000000

mpor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
0000000000 000000000
Seattle, WA
00 As of 0000
0000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Proxim Diagnostics Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000 00000000000 Corporation Seattle, WA 00 0000000000
You’re viewing 1 of 1 competitors. Get the full list »

Proxim Diagnostics Patents

  • 19

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 3

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Proxim Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2737315-A1 Cartridge for diagnostic testing Active 25-Jul-2011 00000000000
EP-2737315-A4 Cartridge for diagnostic testing Active 25-Jul-2011 00000000000 0
EP-2737315-B1 Cartridge for diagnostic testing Active 25-Jul-2011 00000000000
US-20140138260-A1 Cartridge for diagnostic testing Active 25-Jul-2011 00000000000
US-9638663-B2 Cartridge for diagnostic testing Active 25-Jul-2011 G01N27/48
To view Proxim Diagnostics’s complete patent history, request access »

Proxim Diagnostics Executive Team (2)

Name Title Board Seat Contact Info
Mikhail Briman Ph.D Co-Founder, Chief Executive Officer & Board Member
Vikram Joshi Co-Founder & Board Member
To view Proxim Diagnostics’s complete executive team members history, request access »

Proxim Diagnostics Board Members (5)

Name Representing Role Since
Andrew Parker BioMérieux Board Observer 000 0000
Mikhail Briman Ph.D Proxim Diagnostics Co-Founder, Chief Executive Officer & Board Member 000 0000
Sergey Belonozhko Proxim Diagnostics Chairman 000 0000
Thomas Shannon Self Board Member 000 0000
Vikram Joshi Proxim Diagnostics Co-Founder & Board Member 000 0000
To view Proxim Diagnostics’s complete board members history, request access »

Proxim Diagnostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Proxim Diagnostics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BioMérieux Corporation Minority 000 0000 000000 0
GSV Capital Venture Capital Minority 000 0000 000000 0
UCLA Ventures Angel Group Minority 000 0000 000000 0
OKM Capital Venture Capital Minority 000 0000 000000 0
To view Proxim Diagnostics’s complete investors history, request access »

Ready to get started?

Request a free trial